Staci Kallish1, Paige Kaplan. 1. Division of Genetics and Metabolism, Department of Pediatrics, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA.
Abstract
UNLABELLED: Almost half of patients with Gaucher disease are diagnosed by the age of 10 years, and approximately two thirds are diagnosed by the age of 20 years. Besides symptomatic children, some presymptomatic children are being diagnosed through community screening programs and because of affected siblings. In addition, it is anticipated that in the near future, newborn screening for lysosomal diseases such as Gaucher disease will be introduced in the USA, identifying additional pre/nonsymptomatic children. Currently, there is no severity scoring system for children. A validated disease severity scoring system in the pediatric Gaucher population will be essential for classifying disease severity in these children, monitoring their disease progression, making decisions about when to treat them, and monitoring disease improvement with therapy. A severity scoring system will also be helpful in comparing therapeutic options as new therapies are designed. Therefore, a Pediatric Gaucher Severity Scoring System (PGS3) was devised using expert opinion and validated in 26 patients with type 1 Gaucher disease. The PGS3 correlates well with disease severity in patients at diagnosis and over time. CONCLUSION: A practical system that will help clinical management, based on signs and symptoms in children with type 1 Gaucher disease, is presented.
UNLABELLED: Almost half of patients with Gaucher disease are diagnosed by the age of 10 years, and approximately two thirds are diagnosed by the age of 20 years. Besides symptomatic children, some presymptomatic children are being diagnosed through community screening programs and because of affected siblings. In addition, it is anticipated that in the near future, newborn screening for lysosomal diseases such as Gaucher disease will be introduced in the USA, identifying additional pre/nonsymptomatic children. Currently, there is no severity scoring system for children. A validated disease severity scoring system in the pediatric Gaucher population will be essential for classifying disease severity in these children, monitoring their disease progression, making decisions about when to treat them, and monitoring disease improvement with therapy. A severity scoring system will also be helpful in comparing therapeutic options as new therapies are designed. Therefore, a Pediatric Gaucher Severity Scoring System (PGS3) was devised using expert opinion and validated in 26 patients with type 1 Gaucher disease. The PGS3 correlates well with disease severity in patients at diagnosis and over time. CONCLUSION: A practical system that will help clinical management, based on signs and symptoms in children with type 1 Gaucher disease, is presented.
Authors: J Charrow; H C Andersson; P Kaplan; E H Kolodny; P Mistry; G Pastores; B E Rosenbloom; C R Scott; R S Wappner; N J Weinreb; A Zimran Journal: Arch Intern Med Date: 2000-10-09
Authors: R Kauli; R Zaizov; L Lazar; A Pertzelan; Z Laron; A Galatzer; M Phillip; Y Yaniv; I J Cohen Journal: Isr Med Assoc J Date: 2000-02 Impact factor: 0.892
Authors: P Kaplan; A Mazur; O Manor; J Charrow; J Esplin; T J Gribble; R S Wappner; J S Wisch; N J Weinreb Journal: J Pediatr Date: 1996-07 Impact factor: 4.406
Authors: Neal J Weinreb; Maria D Cappellini; Timothy M Cox; Edward H Giannini; Gregory A Grabowski; Wuh-Liang Hwu; Henry Mankin; Ana Maria Martins; Carolyn Sawyer; Stephan vom Dahl; Michael S Yeh; Ari Zimran Journal: Genet Med Date: 2010-01 Impact factor: 8.822
Authors: M Maas; T Hangartner; G Mariani; K McHugh; S Moore; G A Grabowski; P Kaplan; A Vellodi; J Yee; L Steinbach Journal: Skeletal Radiol Date: 2008-03 Impact factor: 2.199
Authors: Marcio Andrade-Campos; Pilar Alfonso; Pilar Irun; Judith Armstrong; Carmen Calvo; Jaime Dalmau; Maria-Rosario Domingo; Jose-Luis Barbera; Horacio Cano; Maria-Angeles Fernandez-Galán; Rafael Franco; Inmaculada Gracia; Miguel Gracia-Antequera; Angela Ibañez; Francisco Lendinez; Marcos Madruga; Elena Martin-Hernández; Maria Del Mar O'Callaghan; Alberto Pérez Del Soto; Yolanda Ruiz Del Prado; Ignacio Sancho-Val; Pablo Sanjurjo; Miguel Pocovi; Pilar Giraldo Journal: Orphanet J Rare Dis Date: 2017-05-03 Impact factor: 4.123
Authors: Andrew J Degnan; Victor M Ho-Fung; Rebecca C Ahrens-Nicklas; Christian A Barrera; Suraj D Serai; Dah-Jyuu Wang; Can Ficicioglu Journal: Insights Imaging Date: 2019-07-10